Wellington Management Group LLP Nurix Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$503 Billion
Q1 2025

A detailed history of Wellington Management Group LLP transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 3,188,742 shares of NRIX stock, worth $34.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,188,742

Holding current value

$34.9 Million

% of portfolio

0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$11.88 - $20.15 $37.9 Million - $64.3 Million	3,188,742 New	3,188,742 $37.9 Million
Q4 2024 Feb 12, 2025	BUY	$18.64 - $28.14 $1.95 Million - $2.94 Million	104,500 Added 3.0%	3,586,605 $67.6 Million
Q3 2024 Nov 14, 2024	BUY	$18.93 - $25.69 $5.3 Million - $7.2 Million	280,240 Added 8.75%	3,482,105 $78.2 Million
Q2 2024 Aug 13, 2024	BUY	$12.02 - $21.3 $35.7 Million - $63.2 Million	2,968,729 Added 1273.39%	3,201,865 $66.8 Million
Q1 2024 May 15, 2024	BUY	$7.77 - $15.66 $1.81 Million - $3.65 Million	233,136 New	233,136 $3.43 Million
Q4 2023 Feb 12, 2024	BUY	$4.25 - $10.71 $872,627 - $2.2 Million	205,324 New	205,324 $2.12 Million
Q3 2023 Nov 14, 2023	BUY	$7.86 - $10.08 $32,721 - $41,963	4,163 Added 2.95%	145,053 $1.14 Million
Q2 2023 Aug 14, 2023	BUY	$8.7 - $13.28 $612,140 - $934,394	70,361 Added 99.76%	140,890 $1.41 Million
Q1 2023 May 12, 2023	SELL	$8.56 - $13.26 $21,186 - $32,818	-2,475 Reduced 3.39%	70,529 $626,000
Q4 2022 Feb 13, 2023	SELL	$9.86 - $14.59 $15,036 - $22,249	-1,525 Reduced 2.05%	73,004 $801,000
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $264,170 - $424,429	21,425 Added 40.35%	74,529 $971,000
Q2 2022 Aug 15, 2022	SELL	$7.88 - $14.82 $6.22 Million - $11.7 Million	-789,269 Reduced 93.7%	53,104 $673,000
Q1 2022 May 16, 2022	SELL	$12.94 - $29.65 $4.14 Million - $9.49 Million	-319,943 Reduced 27.53%	842,373 $11.8 Million
Q4 2021 Feb 11, 2022	SELL	$26.43 - $34.5 $1.68 Million - $2.2 Million	-63,742 Reduced 5.2%	1,162,316 $33.6 Million
Q3 2021 Nov 15, 2021	SELL	$22.71 - $36.69 $3.83 Million - $6.19 Million	-168,833 Reduced 12.1%	1,226,058 $36.7 Million
Q2 2021 Aug 16, 2021	BUY	$24.21 - $35.89 $834,397 - $1.24 Million	34,465 Added 2.53%	1,394,891 $37 Million
Q1 2021 May 17, 2021	SELL	$26.98 - $50.17 $29.3 Million - $54.5 Million	-1,087,158 Reduced 44.42%	1,360,426 $42.3 Million
Q4 2020 Feb 12, 2021	SELL	$22.85 - $48.44 $21 Million - $44.6 Million	-920,938 Reduced 27.34%	2,447,584 $80.3 Million
Q3 2020 Nov 16, 2020	BUY	$16.05 - $34.91 $54.1 Million - $118 Million	3,368,522 New	3,368,522 $117 Million

Others Institutions Holding NRIX

# of Institutions

188

Shares Held

67.2M

Call Options Held

318K

Put Options Held

42.4K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $516M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Nurix Therapeutics, Inc. Transaction History